Background Anemia at hemodialysis (HD) initiation is common. Correcting low hemoglobin
(Hgb) before HD initiation may improve survival by avoiding potential harms of chronic …

Background: Incident hemodialysis patients have a high mortality risk within the first months
after dialysis initiation. Pre-end-stage renal disease (ESRD) factors like anemia …

Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment
variables updated over time. Background The objective of this study was to gain insight into …

Renal anemia is caused by the deficiency of endogenous erythropoietin (Epo) due to renal
dysfunction. We think that it is possible to slow the progression of chronic kidney disease …

In the last decade the nephrology community has learned much about the impact of anemia
on patients with kidney disease. Therapy of anemia can correct many of the symptoms which …

Whether and how anemia treatment with erythropoiesis stimulating agents (ESAs) before
hemodialysis initiation may be associated with lower mortality after dialysis initiation is …

Background Hemoglobin levels usually decline before dialysis initiation. The influence of
overhydration on anemia progression and iron sequestration is poorly documented …

Background Anemia is a major risk factor that contributes to mortality in patients with chronic
kidney disease. There is controversy over the optimal hemoglobin (Hb) target in these …

Anemia is a common complication of chronic renal failure (CRF). With the availability of
recombinant human erythropoietin (rhEPO) over the last decade, much progress has been …

Although treating anemia of chronic kidney disease by erythropoiesis-stimulating agents
(ESA) may improve survival, most studies have examined associations between baseline …